Squarepoint Ops LLC Kronos Bio, Inc. Transaction History

Squarepoint Ops LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.02 - $1.3 $46,581 - $59,368	-45,668 Reduced 29.77%	107,754 $140,000
Q4 2023 Feb 14, 2024	SELL	$0.75 - $1.49 $54,178 - $107,634	-72,238 Reduced 32.01%	153,422 $191,000
Q2 2023 Aug 14, 2023	BUY	$1.24 - $1.92 $222,669 - $344,778	179,572 Added 389.63%	225,660 $388,000
Q1 2023 May 15, 2023	BUY	$1.34 - $2.62 $21,265 - $41,579	15,870 Added 52.52%	46,088 $67,000
Q4 2022 Feb 14, 2023	BUY	$1.44 - $3.44 $43,513 - $103,949	30,218 New	30,218 $48,000
Q3 2021 Nov 15, 2021	SELL	$18.17 - $24.7 $511,249 - $694,983	-28,137 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$20.08 - $29.02 $564,990 - $816,535	28,137 New	28,137 $674,000

19.8M

9.3K

100

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $51.1M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.